Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10005824 Selective PYY compounds and uses thereof

Patent 10005824 was granted and assigned to Novo Nordisk on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+430 characters)
Article

Patent abstract

The invention relates to PYY compounds with the amino acid modifications 7Lys, 30Trp, and 31Leu, and in addition to these, 22Ile and/or 28Tyr, and derivatives thereof. The compounds of the invention are selective Y2 receptor agonists. The invention also relates to pharmaceutical compositions comprising such PYY compounds and pharmaceutically acceptable excipients, as well as the medical use of the PYY compounds.

Edits on 17 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11647773 Production methods for steviol glycosides compositions
0
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 28 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novo Nordisk
Novo Nordisk
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100058240
Date of Patent
June 26, 2018
0
Patent Application Number
156354560
Date Filed
June 28, 2017
0
Patent Citations Received
‌
US Patent 10246497 Selective PYY compounds and uses thereof
0
‌
US Patent 11229229 Steviol glycosides compositions, production methods and uses
0
‌
US Patent 10583172 HPYY(1-36) having a beta-homoarginine substitution at position 35
0
Patent Primary Examiner
‌
Marcela M Cordero Garcia
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novo Nordisk
Novo Nordisk
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100058240
Date of Patent
June 26, 2018
0
Patent Application Number
156354560
Date Filed
June 28, 2017
0
Patent Citations Received
‌
US Patent 10246497 Selective PYY compounds and uses thereof
0
‌
US Patent 11229229 Steviol glycosides compositions, production methods and uses
0
‌
US Patent 10583172 HPYY(1-36) having a beta-homoarginine substitution at position 35
0
Patent Primary Examiner
‌
Marcela M Cordero Garcia
0
Edits on 2 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10583172 HPYY(1-36) having a beta-homoarginine substitution at position 35
Edits on 27 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11229229 Steviol glycosides compositions, production methods and uses
Edits on 25 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 25 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10246497 Selective PYY compounds and uses thereof
Edits on 20 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10005824 Selective PYY compounds and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
Novo Nordisk
Novo Nordisk
Current assignee
Novo Nordisk
Novo Nordisk
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10005824
Date of patent
June 26, 2018
Patent application number
15635456
Date Filed
June 28, 2017
Patent primary examiner
‌
Marcela M Cordero Garcia

Find more entities like US Patent 10005824 Selective PYY compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.